Chapter 9 Therapeutic drug monitoring of antiepileptic drugs

Handbook of Analytical Separations

Volumn 5, Issue , 2004, Pages 221-253

  Johannessen, Svein I ^a  

^a National Center for Epilepsy   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 67649394335     PISSN: 15677192     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1567-7192(04)80010-X     Document Type: Chapter

References (189)

1. Choonara I.A., and Rane A. Clin. Pharmacokinet. 18 (1990) 318-328
2. Eadie M.J. Ther. Drug Monit. 16 (1994) 458-468
3. Mattson R.H. Epilepsia 36 (1995) 22-29
4. Johannessen S.I. In: Levy R.H., Mattson R.H., and Meldrum B.S. (Eds). Antiepileptic drugs. 4th ed (1995), Raven Press, New York 179-187
5. McKee P.J.W., and Brodie M.J. In: Engel Jr. J., and Pedley T.A. (Eds). Epilepsy: A comprehensive textbook (1998), Lippincott-Raven, New York 1181-1194
6. E. P. Clin. Pharmacokinet 38 (2000) 191-204
7. Tomson T., and Johannessen S.I. Eur. J. Clin. Pharmacol. 55 (2000) 697-705
8. Commission on Antiepileptic Drugs. Epilepsia 34 (1993) 585-587
9. Buchthal F., and Svensmark O. Epilepsia 1 (1960) 373-384
10. Pitlick W.H. Antiepileptic drug interactions (1989), Demos Publications, New York
11. Kutt H. In: Wyllie E. (Ed). The treatment of epilepsy. Principles and practice (1993), Lea & Febiger, Philadelphia/London 775-784
12. Patsalos P., and Duncan J.S. Drug Safety 9 (1993) 156-184
13. Pippenger C.E., Penry J.K., and Kutt H. Antiepileptic drugs: Quantitative analysis and interpretation (1978), Raven Press, New York
14. Meijer J.W.A. Acta Neurol. Scand. 83 (1991)
15. Johannessen S.I. In: Levy R.H., Mattson R.H., and Meldrum B.S. (Eds). Antiepileptic drugs. 4th ed (1995), Raven Press, New York 243-270
16. Pippenger C.E., Penry J.K., White B.G., Daly D.D., and Buddington R. Arch. Neurol. 35 (1976) 351-355
17. Wilson J.F., Tsanaclis L.M., Williams J., Tedstone J.E., and Richens A. Ther. Drug Monit. 11 (1989) 185-195
18. Wilson J.F., Tsanaclis L.M., Perrett J.E., Williams J., Wicks J.F., and Richens A. Ther. Drug Monit. 14 (1992) 98-106
19. Johannessen S.I. Ther. Drug Monit. 3 (1981) 17-37
20. Vaida F.J.E., and Aicardi J. Dev. Med. Child Neurol. 25 (1983) 660-671
21. Turnbull D.M., Rawlins M.D., Weightman D., and Chadwick D.W. J. Neurol. Neurosurg. Psychiatry 47 (1984) 231-234
22. Schmidt D., Einicke I., and Haenel F. Arch. Neurol. 43 (1986) 263-265
23. Shorvon S.D., Galbraith A.W., Laundy M., Vydelingum L., and Reynolds E.H. In: Johannessen S.I., Morselli PL., Pippenger C.E., Richens A., Schmidt D., and Meinardi H. (Eds). Antiepileptic therapy: advances in drug monitoring (1980), Raven Press, New York 213-220
24. Strandjord R.E., Johannessen S.I., and Johannessen S.I. In: Morselli P.L., Pippenger C.E., Richens A., Schmidt D., and Meinardi H. (Eds). Antiepileptic therapy: advances in drug monitoring (1980), Raven Press, New York 229-235
25. Kutt H., and Penry J.K. Arch. Neurol. 31 (1974) 283-288
26. Twyman R.E., Rogers C.J., and Macdonald R.L. Ann. Neurol. 25 (1989) 213-220
27. Johannessen S.I. Behav. Neurol. 3 (1990) 1-11
28. Battino D., Estienne M., and Avanzini G. Clin. Pharmocokinet. 29 (1995) 257-286
29. Brodie M.J., and Dichter M.A. N. Eng.J. Med. 334 (1996) 168-175
30. Mattson R.H., Cramer J.A., Collins J.F., Smith D.B., Delgado-Escueta A., Browne T.R., Williamson P.D., Treiman D.M., McNamara J.O., and McCutchen C.B. N. Eng.J. Med. 313 (1985) 145-151
31. Rambeck B., and Meijer J.W.A. Arzneim. Forsch. 29 (1979) 99-103
32. Rambeck B., and Meijer J.W.A. Ther. Drug Monit. 2 (1980) 385-396
33. Rambeck B., Riedmann M., and Meijer J.W.A. Ther. Drug Monit. 3 (1981) 377-395
34. Meijer J.W.A., Rambeck B., and Riedman M. Ther. Drug Monit. 5 (1983) 39-53
35. Wad N. J. Chromatogr. 305 (1984) 127-133
36. Wang S.T., and Peter F. Clin. Chem. 31 (1985) 493-494
37. Thomas K.C., Hullin D.A., and Davis S.J. Ther. Drug Monit. 13 (1991) 172-176
38. Seltzer M.E. Ann. Neurol. 3 (1978) 202-206
39. Battino D., Estienne M., and Avanzini G. Clin. Pharmocokinet. 29 (1995) 241-369
40. Part 20. Bruni J., and Wilder B.J. In: Vinken P.J., and Bruyn G. (Eds). Intoxications of the nervous system. Handbook of clinical neurology Vol. 37 (1979), North-Holland, New York 199-222
41. Lund L. Arch. Neurol. 31 (1974) 289-294
42. Gallagher B.B., Baumel I.P., Mattson R.H., and Woodbury S.G. Neurology 23 (1973) 145-149
43. Janz D. Acta Neurol. Scand. 72 (1985) 449-459
44. Schottelius D.D., and Fincham R.W. In: Pippenger C.E., Penry J.K., and Kutt H. (Eds). Antiepileptic drugs: quantitative analysis and interpretation (1978), Raven Press, New York 273-282
45. McLean M.J., and MacDonald R.L. J. Pharmacol. Exp. Ther. 238 (1986) 727-738
46. Snead O.C., and Hosey L.C. N. Engl. J. Med. 313 (1985) 916-921
47. Holmes G.L. In: Levy R.H., Mattson R.H., and Meldrum B.S. (Eds). Antiepileptic drugs. 4th ed (1995), Raven Press, New York 567-579
48. Cereghino J.J. In: Penry J.K., and Daly D.D. (Eds). Advances in neurology Vol 11 (1975), Raven Press, New York 309-329
49. Dam M., Jensen A., and Christiansen J. Acta Neurol. Scand. 60 (1975) 33-38
50. Eichelbaum M., Bertilsson L., Lund L., Palmer J., and Sjöqvist F. Eur. J. Clin. Pharmacol. 9 (1976) 417-421
51. Monaco F., Riccio A., Benna P., Covacich A., Durelli L., Fantini M., Furlan P.M., Gilli M., Mutani R., Troni W., Gerna M., and Morselli P.L. Neurology 26 (1976) 936-943
52. Callaghan N., O'Callaghan M., Duggan B., and Feely M. J. Neurol. Neurosurg. Psychiatry 41 (1978) 907-912
53. Schoeman J.F., Elyas A.A., Brett E.M., and Lascelles P.T. Dev. Med. Child Neurol. 26 (1984) 756-764
54. Johannessen C.U., Petersen D., Fonnum F., and Hassel B. Epilepsy Res. 47 (2002) 247-256
55. Löscher W. CNS Drugs 16 (2002) 669-694
56. Mattson R.H., Cramer J.A., and Collins J.F. N. Eng. J. Med. 327 (1992) 765-771
57. Jeavons P.M. Epilepsia 25 (1984) S50-S55
58. Dreifuss F.E., and Langer D.H. Am. J. Med. 84 (1988) 39-41
59. Herzog A.G., and Schachter S.C. Epilepsia 42 (2001) 311-315
60. Gram L., Flachs H., Würtz-Jørgensen A., Parnas J., and Andersen B. Epilepsia 20 (1979) 303-311
61. Henriksen O., and Johannessen S.I. In: Johannessen S.I., Morselli P.L., Pippenger C.E., Richens A., Schmidt D., and Meinardi H. (Eds). Antiepileptic therapy: advances in drug monitoring (1980), Raven Press, New York 253-261
62. Henriksen O., and Johannessen S.I. Acta Neurol. Scand. 65 (1982) 504-523
63. Kumps A., and Mardens Y. Clin. Chem. 26 (1980) 1759
64. Odusote K.A., and Sherwin A.L. Ther. Drug Monit. 3 (1981) 103-106
65. Nishioka R., Kawai S., and Toyoda S. J. Chromatogr. 277 (1983) 356-360
66. Kushida K., and Ishizaki T. J. Chromatogr. 338 (1985) 131-139
67. Coulter D.A., Hyuguenard J.R., and Price D.A. Ann. Neurol. 25 (1989) 582-593
68. Berkovic S.F., Andermann F., Andermann E., and Gloor P. Neurology 37 (1987) 993-1000
69. Sato S., White B.G., and Penry J.K. Neurology 32 (1982) 157-163
70. Dreifuss F.E. In: Levy R.H., Mattson R.H., and Meldrum B.S. (Eds). Antiepileptic drugs (1995), Raven Press, New York 675-679
71. Penry J.K., Porter R.J., and Dreifuss F.E. In: Woodbury D.M., Penry J.K., and Schmidt R.P. (Eds). Antiepileptic drugs (1972), Raven Press, New York 431-441
72. Wad N. J. Chromatogr. 338 (1985) 460-462
73. Sato S., and Malow B.A. In: Levy R.H., Mattson R.H., and Meldrum B.S. (Eds). Antiepileptic drugs. 4th ed (1995), Raven Press, New York 725-734
74. Sjö O., Hvidberg E.F., Naestoft J., and Lund M. Eur. J. Clin. Pharmacol. 8 (1975) 249-254
75. Sato S., Penry J.K., Dreifuss F.E., and Dyken PR. Neurology (Minneapolis) 27 (1977) 371
76. Mikkelsen B., Birket-Smith E., Holm P., Lund M., Vestmark S., and Olsen P.Z. Acta Neurol. Scand. 60 (1975) 55-61
77. Baruzzi A., Bordo B., Bossi L., Castelli D., Gerna M., Tognoni G., and Zagnoni P. Int. J. Clin. Pharmacol. 15 (1977) 403-408
78. Gerna M., and Morselli P.L. J. Chromatogr. 115 (1976) 445-450
79. Zilli M.A., and Nisi G. J. Chromatogr. 378 (1986) 492-497
80. Carvalho D., and Lanchote V.L. Ther. Drug Monit. 13 (1991) 55-63
81. Trimble M.R. In: Resor S.R.J., and Kutt H. (Eds). The medical treatment of epilepsy (1992), Marcel Dekker, New York 319-328
82. Koeppen D.A. In: Hindmarch I., Stonier P.D., and Trimble M.R. (Eds). Clobazam - Royal Society of Medicine International Congress Symposium Series No. 74 (1985), Royal Society of Medicine, London 149-153
83. Wolf P. In: Hindmarch I., Stonier P.D., and Trimble M.R. (Eds). International Congress and Symposium Series No. 74 (1985), Royal Society of Medicine, London 167-171
84. Robertson M.M. Epilepsia 27 (1986) S27-S41
85. Streete J.M., Berry D.J., and Newbery J.E. Ther. Drug Monit. 13 (1991) 339-344
86. Wang J., Hug D., Gautschi K., and Wieser H.G. J. Epilepsy 6 (1993) 180-184
87. Badcock N.R., and Zoanetti G.D. J. Chromatogr. 421 (1987) 147-154
88. Schmutz M., Brugger F., Gentsch C., McLean M.J., and Olpe H.R. Epilepsia 35 (1994) S47-S50
89. Lloyd P., Flesch G., and Dieterle W. Epilepsia 35 (1994) S10-S13
90. Baruzzi A., Albani R., and Riva R. Epilepsia 35 (1994) 14-19
91. Dam M., Ekberg R., Lóyning Y., Waltimo O., and Jakobsen K. Epilepsy Res. 3 (1989) 70-76
92. Friis M.L., Kristensen O., Boas J., Dalby M., Deth S.H., Gram L., Mikkelsen M., Pedersen B., Sabers A., and Worm-Petersen J. Acta Neurol. Scand. 87 (1993) 224-227
93. Van Parys J.A.P., and Meinardi H. Epilepsy Res. 84 (1994) 224-227
94. Borusiak P., Korn-Merker E., and Holert N. J. Epilepsy 11 (1998) 355-360
95. Johannessen S.I., Battino D., Berry D.J., Bialer M., Kramer G., Tomson T., and Patsalos P.N. Ther. Drug Monit. 25 (2003) 347-363
96. Von Unruh G.E., and Paar W.D. J. Chromatogr. 345 (1985) 67-76
97. Elyas A.A., Goldberg V.D., and Patsalos P. J. Chromatogr. 528 (1990) 473-479
98. Rouan M.C., Souppart C., Alif L., Mocs D., Lecaillon J.B., and Bodbillon J. J. Chromatogr. 667 (1995) 307-313
99. Levert H., Odou P., and Robert H. J. Pharm. Biomed. Anal. 15 (2002) 517-525
100. Flesch G., Francotte E., Hell F., and Degan P.H. J. Chromatogr. 581 (1992) 147-151
101. Volosov A., Bialer M., Xiaodong S., Perucca E., Sintov A., and Yagen B. J. Chromatogr. 738 (2000) 419-425
102. Pichini S., Altieri I., Passa A.R., Rosa M., Zuccaro P., and Pacifici R. J. Liq. Chromatogr. 18 (1995) 1533-1541
103. Mumford J.P., and Cannon D.J. Epilepsia 35 (1994) S25-S28
104. Schechter P.J. Brit. J. Clin. Pharmacol. 27 (1989) S19-S22
105. Malmgren K., Ben-Menachem E., and Frisén L. Epilepsia 42 (2001) 609-616
106. Gram L., Lyon B.B., and Dam M. Acta. Neurol. Scand. 68 (1983) 34-39
107. Patsalos P.N. Ann. Clin. Biochem. 36 (1999) 10-19
108. Grove J., Alken R.G., and Schechter P.J. J. Chromatogr. 306 (1984) 383-387
109. Smithers J.A., Lang J.F., and Okerholm R.A. J. Chromatogr. 341 (1985) 232-238
110. Tsanaclis L.M., Wicks J., Williams J., and Richens A. Ther. Drug Monit. 13 (1991) 251-253
111. Löscher W., Fassbender C.P., Gram L., Gramer M., Horstermann D., Zahner B., and Stefan H. Epilepsy Res. 14 (1993) 245-255
112. Ratnaraj N., and Patsalos PN. Ther. Drug Monit. 20 (1998) 430^34
113. Chollet D.F., Goumaz L., Juliano C., Anderegg G., Chromatogr J., and Biomed B. Sci. Appl. 746 (2000) 311-314
114. George S., Gill L., and Braithwaite R.A. Ann. Clin. Biochem. 37 (2000) 338-342
115. Yuen A.W.C. Epilepsia 35 (1994) S33-S36
116. Goa K.L., Ross S.R., and Chrisp P. Drugs 46 (1993) 152-176
117. Sabers A., Buchholt J.M., Ulldall P., and Hansen E.L. Epilepsy Res. 47 (2001) 151-154
118. McKee P.J.W., and Brodie M.J. In: Shorvon S., Dreifuss F., Fish D., and Thomas D. (Eds). The treatment of epilepsy (1996), Blackwell Science, Oxford 438-445
119. Brodie M.J. Lancet 339 (1992) 1397-1400
120. Morris R.G., Black A.B., Harris A.L., Batty A.B., and Sallustio B.C. Br. J. Clin. Pharmacol. 46 (1998) 547-551
121. Fraser A.D., MacNeil W., Isner A.R., and Camfield PR. Ther. Drug Monit. 17 (1995) 174-178
122. George S., Wood A.J., and Braithwaite R.A. Ann. Clin. Biochem. 32 (1995) 584-588
123. Forssblad E., Eriksson A.S., and Beck O. J. Pharmaceut. Biomed. Anal. 14 (1996) 755-758
124. Lensmeyer G.L., Gidal B.E., and Wiebe D.A. Ther. Drug Monit. 19 (1997) 292-300
125. Croci D., Salmaggi A., de Grazia U., and Barnardi G. Ther. Drug Monit. 23 (2001) 665-668
126. Petroff O.A.C., Rothman D.L., Behar K.L., Lamoureux D., and Mattson R.H. Ann. Neurol. 39 (1996) 95-99
127. Goa K.L., and Sorkin E.M. Drugs 46 (1993) 409-427
128. Dichter M.A., and Brodie M.J. N. Eng.J. Med. 334 (1996) 1583-1589
129. Ramsay R.E. Neurology 44 (1994) S23-S30
130. Wilson E.A., Sills GJ., Forrest G., and Brodie M.J. Epilepsy Res. 29 (1998) 161-166
131. Hengy H., and Kolle E.U. J. Chromatogr. 341 (1985) 473-478
132. Hooper W.E., Kavanagh M.C., and Dickinson R.G. J. Chromatogr. 529 (1990) 167-174
133. Wad N., and Krämer G. J. Chromatogr. B. Biomed. Sci. Appl. 701 (1998) 154-158
134. Ifa D.R., Falci M., Moraes M.E., Bezerra F.A., Moraes M.O., and de Nucci G. J. Mass. Spectrom 36 (2001) 188-194
135. Kushnir M.M., Crossett J., Brown P.I., and Urry K.M. J. Anal. Toxicol. 23 (1999) 1-6
136. Langtry H.D., Gillis J.C., and Davis R. Drugs 54 (1997) 752-773
137. Ramsay R.E., Slater J.D., and French J.A. In: Dichter M.A., and Leppik I.E. (Eds). New antiepileptic drug development, preclinical and clinical aspects. Epilepsy Res. (1993), Elsevier, Amsterdam 45-67
138. Johannessen S.I. Epilepsia 3 (2000) S18-S23
139. Faught E., Wilder B.J., Ramsay R.E., Reife R.A., Kramer L.D., Pledger G., and Karim R.M. Neurology 46 (1996) 1684-1690
140. Stephen L.J., Sills G.J., and Brodie M.J. Epilepsia 41 (2000) 977-980
141. Christensen J., Poulsen J.H., Andreasen F., and Dam M. Epilepsia 42 (2001) 178
142. Holland M.L., Uetz J.A., and Kung T.N.G. J. Chromatogr. 433 (1988) 276-281
143. Riffitts J.M., Gisclon L.G., Stubbs R.J., and Palmer M.E. J. Pharm. Biomed. Anal. 19 (1999) 363-371
144. Tang P.H., Miles M.V., Glauser T.A., Coletta L., Doughman N., Doose D., Frey M., and DeGrauw A. Ther. Drug. Monit. 22 (2000) 195-201
145. Mozayani A., Carter J., and Nix R. J. Anal. Toxicol. 23 (1999) 556-558
146. Chen S., and Carvey P. Rapid Commun. Mass. Spectrom. 15 (2001) 159-163
147. Contin M., Riva R., Albani F., Baruzzi A., and Biomed J.Chromatogr.B. Sci. AppL 761 (2001) 133-137
148. Christensen J., Højskov C.S., and Poulsen J.H. Ther. Drug Monit. 24 (2002) 658-664
149. Berry D.J., and Patsalos P.N. Ther. Drug Monit. 22 (2000) 460-464
150. Kleckner N.W., Glazewski J.C., Chen C.C., and Moscrip T.D. J. Pharmacol. Exp. Ther. 289 (1999) 886-894
151. Sofia R.D., Kramer L., Perhach J.L., and Rosenberg A. In: Pisani F., Perucca E., Avanzini G., and Richens A. (Eds). New antiepileptic drugs. Epilepsy Res. (1991), Elsevier, Amsterdam 103-108
152. Leppik I.E., Dreifuss F.E., Pledger G.W., Graves N.M., Santilli N., Drury I., Tsay J.Y., Jacobs M.P., Bertram E., and Cereghino J.J. Neurology 41 (1991) 1785-1789
153. The F.S.G.i.L.-G.s. N. Engl. J. Med. 328 (1993) 29-33
154. Harden C.L., Trifiletti R., and Kutt H. Epilepsia 37 (1996) 280-283
155. Troupin A.S., Montouris G., and Hussein G. J. Epilepsy 10 (1997) 26-31
156. Remmel R.P., Miller S.A., and Graves N.M. Ther. Drug Monit. 12 (1990) 90-96
157. Annesley T., and Clayton L. Ther. Drug. Monit. 16 (1994) 419-424
158. Romanyshyn L.A., Wichmann J.K., Kucharczyk N., Shumaker R.C., Ward D., and Sofia R.D. Ther. Drug Monit. 16 (1994) 83-89
159. Romanyshyn L.A., Wichmann J.K., Kucharczyk N., and Shumaker R.D. Ther. Drug Monit. 16 (1994) 90-99
160. Rifai N., Fuller D., Law T., and Mikati M. Clin. Chem. 40 (1994) 745-748
161. Mengel H. Epilepsia 35 (1994) S81-S84
162. Brodie M. Epilepsia 36 (1995) S7-S9
163. Ben-Menachem E. Epilepsia 36 (1995) S14-S21
164. Leppik I.E. Epilepsia 36 (1995) S10-S13
165. Schmidt D., Gram L., Brodie M., Kramer G., Perucca E., Kalviainen R., and Elger C.E. Epilepsy Res. 41 (2000) 245-251
166. Rowan A.J., Gustavson I., Shu V., and Sommerville K.W. Epilepsia 38 (1997) 40
167. Gustavson L.E., and Chu S. J. Chromatogr. 574 (1992) 313-318
168. Chollet D.F., Castella E., Goumaz L., and Anderegg G. J. Pharm. Biomed. Anal. 21 (1999) 641-646
169. Cleton A., de Greef H.J., Edelbroek P.M., Voskuyl R.A., and Danhof M. Br. J. Pharmacol. 128 (1999) 1651-1658
170. Noyer M., Gillard M., Matagne A., Henichart J.P., and Wulfert E. Eur. J. Pharmacol. 286 (1995) 137-146
171. Patsalos P.N. Pharmacol. Therapeut. 85 (2000) 77-85
172. Radtke R.A. Epilepsia 42 (2001) S24-S27
173. Privitera M. Epilepsia 42 (2001) S31-S35
174. Stables J.P., Bialer M., Johannessen S.I., Kupferberg H.J., Levy R.H., Loiseau P., and Perucca E. Epilepsy Res. 22 (1995) 235-246
175. Harden C. Epilepsia 42 (2001) 36-39
176. 176 UCB, Data on file, 2001.
177. Ratnaraj N., Doheny H.C., and Patsalos P.N. Ther. Drug Monit. 18 (1996) 154-157
178. Vermeij T.A.C., and Edelbroek P.M. J. Chromatogr. B. Biomed. Appl. 662 (1994) 134-139
179. Peters D.H., and Sorkin E.M. Drugs 45 (1993) 760-787
180. Seino M., Naruto S., Ito T., and Miyazaki H. In: Levy R.H., Mattson R.H., and Meldrum B.S. (Eds). Antiepileptic drugs (1995), Raven Press, New York 1011-1023
181. Mimaki T. Ther. Drug Monit. 20 (1998) 593-597
182. Glauser T.A., and Pippenger C.E. Epilepsia 41 (2000) S6-S15
183. Jürgens U. J. Chromatogr. 36 (1987) 133-240
184. Noguchi H., Tomita N., and Yoshida K. Jpn. Pharmaco. Ther. 16 (1988) 4805-4811
185. Berry D.J. J. Chromatogr. 534 (1990) 173-181
186. Furuno K., Oishi R., Gomita Y., and Eto K. J. Chromatogr.B. Biomed. Appl. 656 (1994) 456-459
187. Shimoyama R., Ohkubo T., and Sugawara K. Biomed. Chromatogr. 13 (1999) 370-372
188. Makino K., Goto Y., Sueyasu M., Futagami K., Kataoka Y., and Oishi R. J. Chromatogr. B. Biomed. Sci. Appl. 695 (1997) 417-425
189. Kalbe K., Nishimura S., Ishii H., Sunahara N., Naruto S., and Kurooka S. Clin. Chem. 37 (1990) 24-27